Adrenocortical Carcinoma - 64 Studies Found
Withdrawn |
: Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer Patients : Adrenocortical Carcinoma : 2008-11-05 :
|
Active, not recruiting |
: Surgery and Heated Chemotherapy for Adrenocortical Carcinoma :
: 2013-04-12 :
|
Not yet recruiting |
: Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma :
: 2017-04-02 :
|
Active, not recruiting |
: Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical Carcinoma :
: 2017-04-26 : Drug: Abiraterone Acetate Cohort 1: |
Active, not recruiting |
: Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma :
: 2007-04-04 |
Completed |
: A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection : Adrenal Cortical Carcinoma : 1999-11-03 : Drug: doxorubicin, vincristine, and etoposide with mitotane |
Recruiting |
: Evaluation of Side Effects of Mitotane : Adrenocortical Carcinoma : 2007-12-04 |
Terminated |
: Possible New Therapy for Advanced Cancer : Adrenocortical Carcinoma : 2012-09-11 : Drug: IL-13-PE IL-13-PE intravenous infusion Other N |
Recruiting |
: Efficacy of Adjuvant Mitotane Treatment (ADIUVO) : Adrenocortical Carcinoma : 2008-10-21 : Drug: MITOTANE mitotane will be administered at a starting dose of 1.5 g/day and increased in case of go |
Recruiting |
: Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma :
|